Fundraising FoxNeuroReserve
Las Vegas, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into NeuroReserve
836 people in our graph share verified history with the NeuroReserve team — schools, employers, funds. One of them is your warm intro.
Shobhit Guptaunlockedknows Edward S. Park · together at PRTM Management Consultants (overlapped)
×11knows the team · via PricewaterhouseCoopers LLP (PwC)
NeuroReserve Inc. is a US consumer nutrition company that develops dietary supplements and food products aimed at supporting long-term brain and cognitive health. Its main product, RELEVATE, is a 17-nutrient softgel-and-capsule regimen formulated around nutrients found in Mediterranean and MIND dietary patterns, alongside offerings such as extra virgin olive oil, creatine and an omega-3 product, guided by a medical and scientific advisory team.
Founders & leadership
NeuroReserve was founded in 2017 by Edward S. Park and Edward Park, Ph.D., M.S..
ES
Edward S. ParkCo-founderEdward S. Park is an Executive Officer and Director at NeuroReserve with a background in pharmaceuticals and nutritional products development. He has held progressively senior roles leading product development, regulatory strategy, and commercial operations at venture-backed companies, including experience with FDA approvals, fundraising, and organizational scaling.
EP
Edward Park, Ph.D., M.S.Founder, CEOBefore starting the company in 2018, he spent four years as Senior Director of Corporate Development at Alcresta Therapeutics and led pharmaceutical and life sciences work as a Senior Manager in PricewaterhouseCoopers' Health Industries Advisory practice. His earlier career included consulting roles at PRTM Management Consultants and commercial and business development positions at Altus Pharmaceuticals and Alnara Pharmaceuticals.
Board
RN
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 5 rounds · 2019–2025
▶$691.2KraisedApr 2025 · 5 investors · Other Health CareRule 506(b)
▶$691.2KraisedApr 2025 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward S. ParkExecutive Officer, Director
- Robert NewellDirector
- Offering amount
- $691.2K
- Amount sold
- $691.2K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedDec 2023 · 34 investors · Other Health CareRule 506(b)
▶$1.4MraisedDec 2023 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert NewellDirector
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.4M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$295KraisedSep 2021 · 14 investors · Other Health CareRule 506(b)
▶$295KraisedSep 2021 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $295K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$240KraisedAug 2020 · 8 investors · Other Health CareRule 506(b)
▶$240KraisedAug 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $475K
- Amount sold
- $240K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$50KraisedMay 2019 · 4 investors · Other Health CareRule 506(b)
▶$50KraisedMay 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward S. ParkExecutive Officer, Director
- Offering amount
- $125K
- Amount sold
- $50K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does NeuroReserve do?
- NeuroReserve Inc. is a US consumer nutrition company that develops dietary supplements and food products aimed at supporting long-term brain and cognitive health. Its main product, RELEVATE, is a 17-nutrient softgel-and-capsule regimen formulated around nutrients found in Mediterranean and MIND dietary patterns, alongside offerings such as extra virgin olive oil, creatine and an omega-3 product, guided by a medical and scientific advisory team.
- Who founded NeuroReserve?
- NeuroReserve was founded by Edward S. Park, Edward Park, Ph.D., M.S. in 2017.
- Who are NeuroReserve's investors?
- NeuroReserve's investors include Reno Seed Fund.
- How much funding has NeuroReserve raised?
- NeuroReserve has disclosed $2.7M raised across 5 rounds.
- Where is NeuroReserve headquartered?
- NeuroReserve is headquartered in Las Vegas, US.